| Section 80.3 - Exceptions, reclassification and exemptions of scheduled controlled substances |
|
| Section 80.135 - Authorization to conduct hypodermic syringe and needle exchange programs |
|
| Section 86-1.20 - Add-ons to the case payment rate per discharge |
|
| Section 86-1.23 - Exempt units and hospitals |
|
| Section 86-1.46 - Empire Clinical Research Investigator Program (ECRIP) |
|
| SubPart 86-8 - Outpatient Services: Ambulatory Patient Group |
|
| Section 86-8.4 - Capital reimbursement and rate add-ons |
|
| Section 88-5.1 - Purpose |
|
| Section 88-5.2 - Requirements |
|
| Section 98-2.1 - Preamble |
|
| Section 98-2.3 - Standard description of the external appeal process |
|
| Section 98-2.4 - Certification of external appeal agents |
|
| Section 98-2.5 - Certification requirements |
|
| Section 98-2.7 - Screening of requests for external appeal |
|
| Section 98-2.8 - Random assignment of external appeals |
|